Granules India Limited has made a regulatory disclosure regarding the allotment of equity shares to promoter group members through conversion of warrants.
Key Transaction Details
- The Share Transfer and Stakeholders Relationship Committee approved the allotment of 2,49,82,906 fully paid-up equity shares of face value of Re. 1/- each
- The allotment was made to members of the Promoter Group investor category
- The shares were allotted upon conversion of warrants after receipt of the balance 75% of the subscription amount
- The meeting approving the allotment was held on September 16, 2026
Financial Details
- Total consideration received: ₹1,461.50 Crores
- Issue price per share: ₹585
- 25% of consideration was received at the time of allotment of warrants
- Remaining 75% was received at the time of conversion
Capital Structure Impact
- Pre-allotment paid-up equity share capital: ₹24,77,96,921 (24,77,96,921 equity shares)
- Post-allotment paid-up equity share capital: ₹27,27,79,827 (27,27,79,827 equity shares)
- The capital increase represents approximately 10% dilution
Outstanding Instruments
Following this allotment, 17,094 warrants issued to the non-promoter investor category remain outstanding for conversion.
Investor Details
Four investors participated in the allotment, all from the Promoter Group category:
1. Ms. Chigurupati Uma Devi
- Pre-issue holding: 92,40,761 shares (3.73%)
- Shares allotted: 2,48,80,342
- Post-issue holding: 3,41,21,103 shares (12.51%)
2. Ms. Chigurupati Priyanka
- Pre-issue holding: 18,18,683 shares (0.73%)
- Shares allotted: 34,188
- Post-issue holding: 18,52,871 shares (0.68%)
3. Ms. Pragnya Chigurupati
- Pre-issue holding: 18,42,035 shares (0.74%)
- Shares allotted: 34,188
- Post-issue holding: 18,76,223 shares (0.69%)
4. Mr. Harsha Chigurupati
- Pre-issue holding: Nil shares
- Shares allotted: 34,188
- Post-issue holding: 34,188 shares (0.01%)
Regulatory Framework
The allotment was made in accordance with Chapter V of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, specifically Regulation 164 which governs warrant exercise pricing.